Related Experiment Videos
Open space swimming test to index antidepressant activity
1Blanchette Rockefeller Neurosciences Institute, West Virginia University, 9601 Medical Center Dr., Johns Hopkins Academic and Research Bldg., Room 319, Rockville, MD 20850, USA. mksun@brni-jhu.org
Journal of Neuroscience Methods
|June 6, 2003
Summary
The open space swimming test effectively predicts antidepressant activity in rats, showing reduced immobility with various antidepressant classes. This objective method offers a sensitive and promising screen for novel antidepressant drugs.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- Depression is characterized by motivational deficits, not physical limitations.
- Existing depression models like the forced swimming test have limitations in objectivity and scoring.
- Developing predictive and objective assays for antidepressant activity is crucial.
Purpose of the Study:
- To evaluate the predictive capability of an open space swimming test for antidepressant drug efficacy in rats.
- To compare the sensitivity and objectivity of the open space swimming test against traditional methods.
Main Methods:
- Rats were subjected to an open space swimming test to measure immobility.
- The effects of imipramine (tricyclic antidepressant), iproniazid (MAOI), mianserin (atypical antidepressant), and alaproclate (SSRI) were assessed.
- Antidepressants were administered repeatedly at 10 mg/kg, three times daily.
Main Results:
- Untreated rats exhibited increased immobility over successive trials.
- All tested antidepressants (imipramine, iproniazid, mianserin, alaproclate) significantly reduced immobility.
- The open space swimming test demonstrated higher sensitivity to drug treatments compared to the forced swimming test.
Conclusions:
- The open space swimming test is a highly predictive and objective assay for antidepressant activity.
- The test's effectiveness across diverse antidepressant classes suggests broad applicability.
- This swimming test shows potential for screening novel antidepressants and understanding depression pathophysiology.